ADIPOQ and COVID-19: In summary, given the rather inconsistent data, often limited by small cohort numbers or independent factors unrelated to COVID-19, such as BMI, there is currently little evidence for adiponectin as a diagnostic or prognostic marker in COVID-19 (Table 1).